Integrative Neurology With LaFaver & Subramanian

Kathrin LaFaver, MD Neurologist, Saratoga Hospital Medical Group, Saratoga Springs, New York

Indu Subramanian, MD Clinical Professor, Department of Neurology, University of California Los Angeles; PADRECC Director, West Los Angeles Veterans Association, Los Angeles, California

Parkinson's Disease Highlights 2023 Neurologists Kathrin LaFaver and Alberto Espay review the top Parkinson's disease research in 2023, including biomarkers and what the data on GLP-1 receptor agonists may mean for future research.
Medscape Neurology, December 15, 2023
Is Most Parkinson's Disease Man-Made? Indu Subramanian interviews Ray Dorsey about the link between environmental toxins and Parkinson's disease and his advocacy work to end this disease.
Medscape Neurology, November 20, 2023
What to Tell Your Patients About Anti-amyloids for Alzheimer's Disease Kathrin LaFaver and Meredith Wicklund discuss indications and contraindications for lecanemab and other anti-amyloids for Alzheimer's disease that may be coming soon.
Medscape Neurology, November 13, 2023
Highlights From the 2023 Movement Disorder Congress Neurologists Kathrin LaFaver and Indu Subramanian discuss highlights from the 2023 International Congress of Parkinson's Disease and Movement Disorders.
Medscape Neurology, October 13, 2023
Diet and Brain: From Processed Foods to the Farmers Market Kathrin LaFaver interviews fellow neurologist Madhureeta Achari on the nutritional deficiencies she checks for and why she invites her patients to the farmers market.
Medscape Neurology, August 31, 2023
2023 World Parkinson Congress Highlights Neurologists Kathrin LaFaver and Indu Subramanian discuss updates from the 2023 World Parkinson Congress and how the multidisciplinary approach is key.
Medscape Neurology, August 07, 2023
Roll Your Eyes at 'Wellness'? So Did This Wellness Officer Indu Subramanian speaks with neurologist-turned-wellness officer Jennifer Bickel about how to really tackle physician burnout and the stigma of mental health.
Medscape Neurology, July 10, 2023
What the PD Biomarker Breakthrough Means in Practice Neurologists Indu Subramanian and Michael Okun discuss the implications of the alpha-synuclein seed amplification assay for the diagnosis and management of Parkinson's disease.
Medscape Neurology, June 21, 2023
Can Artificial Intelligence Help Diagnose Dementia? Kathrin LaFaver interviews David Jones about how artificial intelligence could help in dementia and Alzheimer's diagnosis and management.
Medscape Neurology, June 12, 2023
Top 5 Movement Disorders Highlights From AAN 2023 Kathrin LaFaver discusses the movement disorders presentations that piqued her interest at the 2023 American Academy of Neurology meeting with fellow neurologist Indu Subramanian.
Medscape Neurology, May 17, 2023
General Neurology Needs Recruits and Respect Kathrin LaFaver, MD interviews Louise M. Klebanoff, MD, about her recent viewpoint on why modern neurology fails outpatients and the importance of generalists.
Medscape Neurology, April 24, 2023
Parkinson's Disease: What's Trauma Got to Do With It? Kathrin LaFaver interviews fellow neurologist Indu Subramanian about her paper on childhood trauma and Parkinson's disease and the broader data on trauma-informed neurology care.
Medscape Neurology, March 31, 2023
What Is Contemplative Medicine? Indu Subramanian tells Kathrin LaFaver about the fellowship she did in contemplative medicine and how to integrate mindfulness into work and life.
Medscape Neurology, November 16, 2022
Wellness as Therapy for Parkinson's Disease Kathrin LaFaver, MD, and Indu Subramanian, MD, discuss achievements and goals of the wellness task force of the Movement Disorder Society.
Medscape Neurology, October 24, 2022
Will Parkinson's Disease Therapy Move Past Carbidopa-Levodopa? Kathrin LaFaver, MD, and Indu Subramanian, MD, discuss updates on Parkinson's disease, including highlights of the 2022 International Congress of Parkinson's Disease and Movement Disorders.
Medscape Neurology, October 13, 2022
Why Neurologists Should Care About Reproductive Rights Many neurologic conditions require treatment with teratogenic agents. Abortion bans complicate these treatment decisions.
Medscape Neurology, September 26, 2022
A Novel Treatment and Other Parkinson's Updates From AAN 2022 Dr Kathrin LaFaver and Dr Indu Subramanian discuss promising data with the GLP-1 agonist liraglutide, and other research on Parkinson's disease that caught their attention.
Medscape Neurology, August 17, 2022
An Overlooked Factor in Neurologic Disease Dr Kathrin LaFaver speaks with Dr Indu Subramanian about an approach for addressing loneliness in this vulnerable population.
Medscape Neurology, June 28, 2022
Assessing and Managing Functional Neurologic Disorders Drs Subramanian, LaFaver, and Perez discuss the need for more education on functional movement disorders, a new society devoted to these conditions, and the rise of "TikTok tics" during COVID.
Medscape Neurology, June 16, 2022
The Latest in Movement Disorder Research This year's AAN meeting highlighted differences in outcomes based on patients' backgrounds.
Medscape Neurology, May 19, 2022